{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:42:58Z","timestamp":1792064578472,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd005002","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2007,4,18]],"date-time":"2007-04-18T00:00:00Z","timestamp":1176854400000}}],"reference-count":83,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005002.pub2","type":"journal-article","created":{"date-parts":[[2007,4,3]],"date-time":"2007-04-03T23:45:17Z","timestamp":1175643917000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":95,"title":["Preoperative chemotherapy for women with operable breast cancer"],"prefix":"10.1002","volume":"2021","author":[{"given":"Jos H","family":"van der Hage","sequence":"additional","affiliation":[{"name":"Department of Surgery; Rode Kruis Ziekenhuis (Red Cross Hospital); The Hague Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis JH","family":"van de Velde","sequence":"additional","affiliation":[{"name":"Department of Surgery; Leiden University Medical Centre; Leiden Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven JSD","family":"Mieog","sequence":"additional","affiliation":[{"name":"Department of Surgery; Leiden University Medical Center; Leiden Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayoub","family":"Charehbili","sequence":"additional","affiliation":[{"name":"Department of Surgery; Leiden University Medical Center; Leiden Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,4,18]]},"reference":[{"key":"10.1002\/14651858.CD005002.pub2-BIB0001|cit1","unstructured":"Jakesz R Comparison of pre- vs. postoperative chemotherapy in breast cancer patients: Four-year results of Austrian breast & colorectal cancer study group (ABCSG) trial 7 American Society of Clinical Oncology. Annual Meeting 2001 Abstract 125"},{"issue":"5","key":"10.1002\/14651858.CD005002.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/oxfordjournals.annonc.a057953","article-title":"Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre","volume":"2","author":"Mauriac","year":"1991","journal-title":"Annals of Oncology"},{"issue":"1","key":"10.1002\/14651858.CD005002.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1023\/A:1008337009350","article-title":"Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonie Bordeaux Groupe Sein (IBBGS)","volume":"10","author":"Mauriac","year":"1999","journal-title":"Annals of Oncology"},{"key":"10.1002\/14651858.CD005002.pub2-BIB0004|cit4","unstructured":"Eiermann W Sabadell D Baselga J Vazquez V Guillem Porta V European cooperative trial in operable breast cancer (ECTO): No increased risk of local breast tumor recurrence (LBR) as first and only event after primary systemic therapy (PST) American Society of Clinical Oncology 2003 Abstract 37"},{"issue":"Suppl 16","key":"10.1002\/14651858.CD005002.pub2-BIB0005|cit5","first-page":"Abstract 513","article-title":"European cooperative trial in operable breast cancer (ECTO): Improved freedom from progression (FFP) from adding paclitaxel (T) to doxorubicin (A) followed by cyclophosphamide methotrexate and fluorouracil (CMF)","volume":"23","author":"Gianni","year":"2005","journal-title":"Journal of Clinical Oncology, ASCO Annual Meeting Proceedings"},{"issue":"1","key":"10.1002\/14651858.CD005002.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/bjs.1800820127","article-title":"Prospective randomized study of surgical morbidity following primary systemic therapy for breast cancer","volume":"82","author":"Forouhi","year":"1995","journal-title":"British Journal of Surgery"},{"issue":"22","key":"10.1002\/14651858.CD005002.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1200\/JCO.2001.19.22.4224","article-title":"Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902","volume":"19","author":"Hage","year":"2001","journal-title":"Journal of Clinical Oncology"},{"issue":"12","key":"10.1002\/14651858.CD005002.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/0277-5379(91)90442-G","article-title":"Neoadjuvant chemotherapy in operable breast cancer","volume":"27","author":"Scholl","year":"1991","journal-title":"European Journal of Cancer"},{"issue":"2","key":"10.1002\/14651858.CD005002.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/A:1006339918798","article-title":"Short and long-term effects on survival in breast cancer patients treated by primary chemotherapy: an updated analysis of a randomized trial","volume":"58","author":"Broet","year":"1999","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"10.1002\/14651858.CD005002.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0959-8049(94)90537-1","article-title":"Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6","volume":"30A","author":"Scholl","year":"1994","journal-title":"European Journal of Cancer"},{"issue":"12","key":"10.1002\/14651858.CD005002.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/0959-8049(95)00454-8","article-title":"Breast tumour response to primary chemotherapy predicts local and distant control as well as survival","volume":"31A","author":"Scholl","year":"1995","journal-title":"European Journal of Cancer"},{"key":"10.1002\/14651858.CD005002.pub2-BIB0012|cit12","doi-asserted-by":"crossref","unstructured":"Enomoto K Ikeda T Matsui A Kitajima M Koh J Neoadjuvant therapy in stage II with T>=4CM and stage III breast cancer 6th International Conference Adjuvant therapy for Primary Breast Cancer St Gallen 1998 P73","DOI":"10.1016\/S0959-8049(97)89290-8"},{"key":"10.1002\/14651858.CD005002.pub2-BIB0013|cit13","doi-asserted-by":"crossref","unstructured":"Ostapenko V Pipiriene T Valuckas K Primary chemotherapy in conservative treatment of stage II breast cancer In 6th International Conference Adjuvant therapy for Primary Breast Cancer St Gallen 1998 Abstract P78","DOI":"10.1016\/S0959-8049(97)89295-7"},{"issue":"5","key":"10.1002\/14651858.CD005002.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1023\/A:1011115107615","article-title":"Estrogen-receptor-directed neoadjuvant therapy for breast cancer: results of a randomised trial using formestane and methotrexate, mitozantrone and mitomycin C (MMM) chemotherapy","volume":"12","author":"Gazet","year":"2001","journal-title":"Annals of Oncology"},{"issue":"8","key":"10.1002\/14651858.CD005002.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1200\/JCO.1998.16.8.2672","article-title":"Effect of preoperative chemotherapy on the outcome of women with operable breast cancer","volume":"16","author":"Fisher","year":"1998","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD005002.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/oxfordjournals.jncimonographs.a003469","article-title":"Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18.","volume":"30","author":"Wolmark","year":"2001","journal-title":"Journal of the National Cancer Institute. Monographs"},{"key":"10.1002\/14651858.CD005002.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/annonc\/mdi049","article-title":"Good clinical response of breast cancers to adjuvant chemoendocrine therapy is associated with improved overall survival","volume":"16","author":"Cleator","year":"2005","journal-title":"Annals of Oncology"},{"issue":"11","key":"10.1002\/14651858.CD005002.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1023\/A:1008400706949","article-title":"A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer","volume":"9","author":"Makris","year":"1998","journal-title":"Annals of Oncology"},{"issue":"7","key":"10.1002\/14651858.CD005002.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/oxfordjournals.annonc.a058929","article-title":"Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancer","volume":"5","author":"Semiglazov","year":"1994","journal-title":"Annals of Oncology"},{"issue":"6","key":"10.1002\/14651858.CD005002.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1245\/ASO.2003.12.008","article-title":"Preoperative FLAC\/granulocyte-colony-stimulating factor chemotherapy for stage II breast cancer: a prospective randomized trial","volume":"10","author":"Cowan","year":"2003","journal-title":"Annals of Surgical Oncology"},{"issue":"4","key":"10.1002\/14651858.CD005002.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/jso.10323","article-title":"Randomized trial comparing neo-adjuvant versus adjuvant chemotherapy in operable locally advanced breast cancer (T4b N0-2 M0)","volume":"84","author":"Deo","year":"2003","journal-title":"Journal of Surgical Oncology"},{"issue":"1\/2","key":"10.1002\/14651858.CD005002.pub2-BIB0022|cit22","first-page":"147 (Abstract 6","article-title":"An institutional experience with preoperative systematic chemotherapy in early stage breast cancer","volume":"27","author":"Hyams","year":"1993","journal-title":"Breast Cancer Research & Treatment"},{"key":"10.1002\/14651858.CD005002.pub2-BIB0023|cit23","unstructured":"Ragaz J Baird R Rebbeck P Trevisan C Goldie J Coldman A Preoperative (neoadjuvant - PRE) versus postoperative (POST) adjuvant chemotherapy (CT) for stage i-II breast cacner (SI-II BC). Long-term analysis of British Columbia randomized trial American Society of Clinical Oncology. Annual Meeting 1997 Abstract 499"},{"issue":"3","key":"10.1002\/14651858.CD005002.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1023\/A:1006194921139","article-title":"Neo-adjuvant chemotherapy for operable breast cancer induces apoptosis","volume":"53","author":"Shao","year":"1999","journal-title":"Breast Cancer Research and Treatment"},{"issue":"1\/2","key":"10.1002\/14651858.CD005002.pub2-BIB0025|cit25","first-page":"148 (Abstract 1","article-title":"Preoperative versus postoperative adjuvant chemotherapy in early operable breast cancer","volume":"27","author":"Stauffer","year":"1993","journal-title":"Breast Cancer Research & Treatment"},{"issue":"1","key":"10.1002\/14651858.CD005002.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/(SICI)1097-0142(19960701)78:1<91::AID-CNCR14>3.0.CO;2-2","article-title":"Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging","volume":"78","author":"Abraham","year":"1996","journal-title":"Cancer"},{"issue":"11","key":"10.1002\/14651858.CD005002.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1093\/annonc\/mdg452","article-title":"Late local recurrences in a randomised trial comparing conservative treatment with total mastectomy in early breast cancer patients","volume":"14","author":"Arriagada","year":"2003","journal-title":"Annals Of Oncology"},{"issue":"12","key":"10.1002\/14651858.CD005002.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1200\/JCO.2004.05.166","article-title":"Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer","volume":"22","author":"Ayers","year":"2004","journal-title":"J Clin Oncol"},{"issue":"13","key":"10.1002\/14651858.CD005002.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1200\/JCO.2005.04.1665","article-title":"Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer:National Surgical Adjuvant Breast and Bowel Project Protocol B-27","volume":"24","author":"Bear","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1002\/14651858.CD005002.pub2-BIB0030|cit30","first-page":"19","article-title":"Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group","volume":"11","author":"Blichert-Toft","year":"1992","journal-title":"Journal National Cancer Institute Monographs"},{"issue":"19","key":"10.1002\/14651858.CD005002.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/jnci\/82.19.1539","article-title":"Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more","volume":"82","author":"Bonadonna","year":"1990","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1002\/14651858.CD005002.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJM199504063321401","article-title":"Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: The results of 20 years of follow-up","volume":"332","author":"Bonadonna","year":"1995","journal-title":"New England Journal of Medicine"},{"issue":"16","key":"10.1002\/14651858.CD005002.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1200\/JCO.2005.07.032","article-title":"Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer","volume":"23","author":"Buzdar","year":"2005","journal-title":"Journal of Clinical Oncology"},{"issue":"9381","key":"10.1002\/14651858.CD005002.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0140-6736(03)14023-8","article-title":"Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer","volume":"362","author":"Chang","year":"2003","journal-title":"Lancet"},{"issue":"9","key":"10.1002\/14651858.CD005002.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1093\/annonc\/mdi276","article-title":"Neoadjuvant vinorelbine\/epirubicin (VE) versus standard adriamycin\/cyclophosphamide (AC) in operable breast cancer: analysis of response and tolerability in a randomised phase III trial (TOPIC 2)","volume":"16","author":"Chua","year":"2005","journal-title":"Annals of Oncology"},{"issue":"9503","key":"10.1002\/14651858.CD005002.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/S0140-6736(05)67887-7","article-title":"Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials","volume":"366","author":"Clarke","year":"2005","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD005002.pub2-BIB0037|cit37","volume-title":"Systematic Reviews in Health Care: Meta-Analysis in Context","author":"Deeks","year":"2001"},{"issue":"9472","key":"10.1002\/14651858.CD005002.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","article-title":"Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials","volume":"365","author":"Early Breast Cancer Trialists' Collaborative Group","year":"2005","journal-title":"Lancet"},{"issue":"7109","key":"10.1002\/14651858.CD005002.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD005002.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0360-3016(97)00917-6","article-title":"Local recurrence after breast-conserving therapy for invasive breast cancer: high incidence in young patients and association with poor survival","volume":"40","author":"Elkhuizen","year":"1998","journal-title":"International Journal of Radiation Oncology Biology Physics"},{"issue":"13","key":"10.1002\/14651858.CD005002.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1200\/JCO.2005.06.156","article-title":"Phase III randomized trial of doxorubicin and docetaxel versus doxorubicin and cyclophosphamide as primary medical therapy in women with breast cancer: an anglo-celtic cooperative oncology group study","volume":"23","author":"Evans","year":"2005","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD005002.pub2-BIB0042|cit42","first-page":"682","article-title":"Taxanes as neoadjuvant chemotherapy for breast cancer: Pooled-analysis of 3120 patients enrolled in 10 randomized trials","volume":"16S","author":"Felici","year":"2005","journal-title":"J Clin Oncol ASCO Annual Meeting Proceedings"},{"key":"10.1002\/14651858.CD005002.pub2-BIB0043|cit43","unstructured":"Ferlay J Bray F Pisani P Parkin DM Cancer Incidence, Mortality and Prevalence Worldwide. GLOBOCAN, Version 1.0 IARC CancerBase No. 5. Lyon, IARCPress, 2001"},{"key":"10.1002\/14651858.CD005002.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1056\/NEJM198902233200801","article-title":"A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors","volume":"320","author":"Fisher","year":"1989","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD005002.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1200\/JCO.1995.13.3.537","article-title":"Preoperative chemotherapy: a model for studying the biology and therapy of primary breast cancer","volume":"13","author":"Fisher","year":"1995","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1002\/14651858.CD005002.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa020128","article-title":"Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation","volume":"347","author":"Fisher","year":"2002","journal-title":"The New England Journal Of Medicine"},{"issue":"14","key":"10.1002\/14651858.CD005002.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/S0959-8049(02)00219-8","article-title":"Local recurrence in the breast after conservative surgery--a study of prognosis and prognostic factors in 391 women","volume":"38","author":"Fredriksson","year":"2002","journal-title":"European Journal of Cancer"},{"issue":"9","key":"10.1002\/14651858.CD005002.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/bjs.4206","article-title":"Risk factors for local recurrence after breast-conserving surgery","volume":"90","author":"Fredriksson","year":"2003","journal-title":"Br J Surg"},{"issue":"4","key":"10.1002\/14651858.CD005002.pub2-BIB0049|cit49","first-page":"263","article-title":"Health-related quality-of-life measurement in randomized clinical trials in breast cancer--taking stock","volume":"95","author":"Goodwin","year":"2003","journal-title":"JNCI Cancer Spectrum"},{"key":"10.1002\/14651858.CD005002.pub2-BIB0050|cit50","first-page":"859","article-title":"Carcinoma of the breast. Criteria of inoperability","volume":"118","author":"Haagensen","year":"1943","journal-title":"The American surgeon"},{"key":"10.1002\/14651858.CD005002.pub2-BIB0051|cit51","first-page":"1032","article-title":"Carcinoma of the breast. Criteria of inoperability","volume":"118","author":"Haagensen","year":"1943","journal-title":"The American surgeon"},{"issue":"15","key":"10.1002\/14651858.CD005002.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1200\/JCO.2005.09.077","article-title":"Changes in gene expression associated with response to neoadjuvant chemotherapy in breast cancer","volume":"23","author":"Hannemann","year":"2005","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1002\/14651858.CD005002.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1002\/1097-0142(197703)39:3<1289::AID-CNCR2820390340>3.0.CO;2-F","article-title":"Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland","volume":"39","author":"Hayward","year":"1977","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD005002.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"issue":"5","key":"10.1002\/14651858.CD005002.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/1097-0142(19830301)51:5<763::AID-CNCR2820510502>3.0.CO;2-C","article-title":"Multimodal treatment of locoregionally advanced breast cancer","volume":"51","author":"Hortobagyi","year":"1983","journal-title":"Cancer"},{"issue":"12","key":"10.1002\/14651858.CD005002.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1002\/1097-0142(19881215)62:12<2507::AID-CNCR2820621210>3.0.CO;2-D","article-title":"Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy","volume":"62","author":"Hortobagyi","year":"1988","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD005002.pub2-BIB0057|cit57","first-page":"155","volume-title":"Textbook of Breast Cancer: A Clinical Guide to Therapy","author":"Hortobagyi","year":"1997"},{"key":"10.1002\/14651858.CD005002.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/978-3-642-83337-3_6","article-title":"Neoadjuvant chemotherapy in the conservative management of breast cancer: a study of 252 patients","volume":"115","author":"Jacquillat","year":"1989","journal-title":"Recent Results in Cancer Research"},{"issue":"13","key":"10.1002\/14651858.CD005002.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1200\/JCO.2003.01.136","article-title":"International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations","volume":"21","author":"Kaufmann","year":"2003","journal-title":"Journal of Clinical Oncology"},{"issue":"6","key":"10.1002\/14651858.CD005002.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1200\/JCO.1991.9.6.1059","article-title":"The impact of breast-conserving treatment and mastectomy on the quality of life of early-stage breast cancer patients: a review","volume":"9","author":"Kiebert","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1002\/14651858.CD005002.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1200\/JCO.1998.16.11.3486","article-title":"Survival advantage of adjuvant chemotherapy in high-risk node-negative breast cancer: Ten-year analysis--an intergroup study","volume":"16","author":"Mansour","year":"1998","journal-title":"Journal of Clinical Oncology"},{"issue":"11","key":"10.1002\/14651858.CD005002.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1038\/sj.bjc.6601835","article-title":"Predictors of patients' choices for breast-conserving therapy or mastectomy: a prospective study","volume":"90","author":"Molenaar","year":"2004","journal-title":"Br J Cancer"},{"issue":"24","key":"10.1002\/14651858.CD005002.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"issue":"6","key":"10.1002\/14651858.CD005002.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1177\/153303460400300602","article-title":"The role of magnetic resonance imaging in diagnosis and management of breast cancer","volume":"3","author":"Pavic","year":"2004","journal-title":"Technol Cancer Res Treat"},{"key":"10.1002\/14651858.CD005002.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/archsurg.1982.01380310005002","article-title":"Chemotherapy before and after mastectomy in stage III breast cancer","volume":"117","author":"Perloff","year":"1982","journal-title":"Archives of surgery"},{"issue":"4","key":"10.1002\/14651858.CD005002.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/cncr.11580","article-title":"Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial","volume":"98","author":"Poggi","year":"2003","journal-title":"Cancer"},{"issue":"4","key":"10.1002\/14651858.CD005002.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/jso.2930220415","article-title":"Preoperative chemotherapy followed by mastectomy for locally advanced breast cancer","volume":"22","author":"Schick","year":"1983","journal-title":"Journal of Surgical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD005002.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1148\/radiology.169.1.3420282","article-title":"Advanced primary breast cancer: assessment at mammography of response to induction chemotherapy","volume":"169","author":"Segel","year":"1988","journal-title":"Radiology"},{"issue":"9","key":"10.1002\/14651858.CD005002.pub2-BIB0069|cit69","first-page":"893","article-title":"Effects of preoperative chemotherapy on the morphology of resectable breast carcinoma","volume":"9","author":"Sharkey","year":"1996","journal-title":"Mod Pathol"},{"issue":"22","key":"10.1002\/14651858.CD005002.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1200\/JCO.2005.04.005","article-title":"Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial","volume":"23","author":"Smith","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1002\/14651858.CD005002.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"issue":"15","key":"10.1002\/14651858.CD005002.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1016\/S0959-8049(03)00572-0","article-title":"Impact of locoregional treatment on the early-stage breast cancer patients: a retrospective analysis","volume":"39","author":"Hage","year":"2003","journal-title":"Eur J Cancer"},{"issue":"14","key":"10.1002\/14651858.CD005002.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/jnci\/92.14.1143","article-title":"Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European organization for research and treatment of cancer 10801 trial","volume":"92","author":"Dongen","year":"2000","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1002\/14651858.CD005002.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0959-8049(98)00301-3","article-title":"Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group","volume":"35","author":"Tienhoven","year":"1999","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1002\/14651858.CD005002.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/00000658-199511000-00002","article-title":"Conservation surgery after primary chemotherapy in large carcinomas of the breast","volume":"222","author":"Veronesi","year":"1995","journal-title":"Ann Surg"},{"issue":"16","key":"10.1002\/14651858.CD005002.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMoa020989","article-title":"Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer","volume":"347","author":"Veronesi","year":"2002","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD005002.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1148\/radiology.198.2.8596827","article-title":"Primary breast cancer: mammographic changes after neoadjuvant chemotherapy, with pathologic correlation","volume":"198","author":"Vinnicombe","year":"1996","journal-title":"Radiology"},{"issue":"17","key":"10.1002\/14651858.CD005002.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1016\/j.ejca.2005.04.040","article-title":"Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer","volume":"41","author":"Voogd","year":"2005","journal-title":"European Journal of Cancer"},{"issue":"9460","key":"10.1002\/14651858.CD005002.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0140-6736(05)17947-1","article-title":"Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer","volume":"365","author":"Wang","year":"2005","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD005002.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1200\/JCO.2000.18.6.1220","article-title":"Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis","volume":"18","author":"Whelan","year":"2000","journal-title":"Journal of Clinical Oncology"},{"issue":"7","key":"10.1002\/14651858.CD005002.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1200\/JCO.2000.18.7.1558","article-title":"Primary systemic therapy in operable breast cancer","volume":"18","author":"Wolff","year":"2000","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1002\/14651858.CD005002.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/bjs.5209","article-title":"Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer","volume":"93","author":"Xing","year":"2006","journal-title":"Br J Surg"},{"key":"10.1002\/14651858.CD005002.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0033-0620(85)80003-7","article-title":"Beta blockade during and after myocardial infarction: an overview of the randomized trials","volume":"27","author":"Yusuf","year":"1985","journal-title":"Progress in Cardiovascular Diseases"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD005002.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T10:47:38Z","timestamp":1644058058000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD005002.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Breast Cancer Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2007,4,18]]},"references-count":83,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005002.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,18]]}}}